The TGA said the decision addressed the "insufficient options" for people with some mental diseases that did not respond to other solutions. This off-label use is technically legal, but a 2015 controversy more than clinics that allegedly skimped on psychiatric supervision and sent clients dwelling to self-inject their ketamine doses https://psychedelicsmart.com.au//blog/